NCT05170828 2026-02-24Cryopreserved MMUD BM With PTCy for Hematologic MalignanciesOssium Health, Inc.Phase 1 Withdrawn
NCT05589896 2026-02-24A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesOssium Health, Inc.Phase 1/2 Recruiting12 enrolled
NCT03802695 2026-02-23A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesOrca Biosystems, Inc.Phase 1 Recruiting300 enrolled
NCT07216443 2026-02-23Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeOrca Biosystems, Inc.Phase 2 Recruiting80 enrolled
NCT06325748 2026-02-12SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDSSenti BiosciencesPhase 1 Active not recruiting21 enrolled
NCT06533579 2026-02-12Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)Vironexis Biotherapeutics Inc.Phase 1/2 Recruiting32 enrolled
NCT07346105 2026-01-16Orca-T Expanded Access Program Study for Patients With Advanced Hematologic MalignanciesOrca Biosystems, Inc.Temporarily not available
NCT04872478 2026-01-08Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALMeryx, Inc.Phase 1 Recruiting50 enrolled